Leishmaniasis and poverty

J Alvar, S Yactayo, C Bern - Trends in parasitology, 2006 - cell.com
Leishmaniasis, a neglected tropical disease, has strong but complex links with poverty. The
burden of leishmaniasis falls disproportionately on the poorest segments of the global …

[HTML][HTML] The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goals

M Bangert, DH Molyneux, SW Lindsay… - Infectious diseases of …, 2017 - Springer
Abstract The Sustainable Development Goals (SDGs) call for an integrated response, the
kind that has defined Neglected Tropical Diseases (NTDs) efforts in the past decade. NTD …

[图书][B] Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030

World Health Organization - 2020 - apps.who.int
Conclusions Neglected tropical diseases (NTDs) are ancient diseases of poverty that
impose a devastating human, social and economic burden on more than 1 billion people …

[HTML][HTML] Complexities of assessing the disease burden attributable to leishmaniasis

C Bern, JH Maguire, J Alvar - PLoS neglected tropical diseases, 2008 - journals.plos.org
Among parasitic diseases, morbidity and mortality caused by leishmaniasis are surpassed
only by malaria and lymphatic filariasis. However, estimation of the leishmaniasis disease …

Combination therapy for visceral leishmaniasis

J van Griensven, M Balasegaram, F Meheus… - The Lancet infectious …, 2010 - thelancet.com
Combination therapy for the treatment of visceral leishmaniasis has increasingly been
advocated as a way to increase treatment efficacy and tolerance, reduce treatment duration …

Liposomal amphotericin B for the treatment of visceral leishmaniasis

LD Saravolatz, C Bern, J Adler-Moore… - Clinical Infectious …, 2006 - academic.oup.com
During the past decade, liposomal amphotericin B has been used with increasing frequency
to treat visceral leishmaniasis (VL). The World Health Organization convened a workshop to …

Chemotherapy in the treatment and control of leishmaniasis

J Alvar, S Croft, P Olliaro - Advances in parasitology, 2006 - Elsevier
Drugs remain the most important tool for the treatment and control of both visceral and
cutaneous leishmaniasis. Although there have been several advances in the past decade …

[HTML][HTML] Visceral leishmaniasis: a global overview

RG Wamai, J Kahn, J McGloin, G Ziaggi - Journal of Global Health …, 2020 - e-jghs.org
The leishmaniases are protozoan infections that are among the neglected tropical diseases
(NTDs). Over one billion people are at risk of these diseases in virtually all continents. These …

Vulnerabilities to and the Socioeconomic and Psychosocial Impacts of the Leishmaniases: A Review

G Grifferty, H Shirley, J McGloin, J Kahn… - Research and reports …, 2021 - Taylor & Francis
The leishmaniases are a group of four vector-borne neglected tropical diseases (NTDs) with
1.6 billion people in some 100 countries at risk. They occur in certain eco-epidemiological …

[HTML][HTML] Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial

A Hailu, A Musa, M Wasunna… - PLoS neglected …, 2010 - journals.plos.org
Background Visceral leishmaniasis (VL) is a major health problem in developing countries.
The untreated disease is fatal, available treatment is expensive and often toxic, and drug …